
L-Thyroxine sodium salt pentahydrate
CAS No. 6106-07-6
L-Thyroxine sodium salt pentahydrate ( Sodium levothyroxine pentahydrate | Levothyroxine )
产品货号. M24609 CAS No. 6106-07-6
L-甲状腺素钠盐五水合物是一种用于甲状腺功能减退症研究的合成激素。 DIO 酶将 L-甲状腺素 (T4) 转化为具有生物活性的甲状腺激素 (三碘甲状腺原氨酸,T3)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥405 | 有现货 |
![]() ![]() |
1G | ¥527 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称L-Thyroxine sodium salt pentahydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述L-甲状腺素钠盐五水合物是一种用于甲状腺功能减退症研究的合成激素。 DIO 酶将 L-甲状腺素 (T4) 转化为具有生物活性的甲状腺激素 (三碘甲状腺原氨酸,T3)。
-
产品描述L-Thyroxine sodium salt pentahydrate?is a synthetic hormone for the research of hypothyroidism.?DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4).
-
体外实验——
-
体内实验Deiodinases (DIOs), which catalyse the conversion of thyroxine (pro-hormone) to the active thyroid hormone, are associated with thyroid stimulating hormone (TSH) levels. DIO1 and DIO2 catalyze activation of thyroid hormone secretion in contrast to DIO3 playing role inactivation of the secretion. Activities of DIO1 and DIO2 play pivotal role in the negative feedback regulation of pituitary TSH secretion. L-Thyroxine (T4) and Triiodothyronine (T3) hormones are known to modulate the expression of ionic channels, pumps and regulatory contractile proteins. Moreover, thyroid hormones have been shown to influence calcium homeostasis and flux responsible for excitation and contractility, with L-Thyroxine and Triiodothyronine modulating its pharmacological control and secretion. In rats fed 12 weeks with the iodine-free diet, a significant decrease in the levels of both Triiodothyronine and L-Thyroxine is observed when compared to the control group fed with standard diet (p<0.001). In the group treated with low doses of L-Thyroxine, an increase in L-Thyroxine levels is observed (p=0.02) while Triiodothyronine levels remain virtually similar to the control group (p=0.19). Rats treated with high doses of L-Thyroxine display a significant increase in both Triiodothyronine and L-Thyroxine circulating concentrations compared to the non-treated hypothyroid group (p<0.001 and p=0.004, respectively) and a significant increase in L-Thyroxine levels when compared to the control values (p=0.03).
-
同义词Sodium levothyroxine pentahydrate | Levothyroxine
-
通路Endocrinology/Hormones
-
靶点THR
-
受体Thyroid Hormone
-
研究领域——
-
适应症——
化学信息
-
CAS Number6106-07-6
-
分子量888.93
-
分子式C15H20I4NNaO9
-
纯度>98% (HPLC)
-
溶解度DMSO:28 mg/mL (31.50 mM)
-
SMILESC1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)[O-])N.O.O.O.O.O.[Na+]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 Jan 11.